Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10020043serious1Date Last Updated18/03/2014receiptdateformat102companynumbPHHY2014GB029621occurcountryGBseriousnessother1duplicate1Date Received18/03/2014transmissiondate02/10/2014primarysourcecountryGB

Primary Source

reportercountryGBqualification3

Patient

Onset Age60Unit of Onset AgeyearsWeight68.3SexFemale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
- 6)
- 7)
- 8)
- 9)
- 10)
- 11)
- 12)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionMultiple chemical sensitivityOutcomeNot recovered/not resolved

2)

reactionmeddraversionpt17.0ReactionDisorientationOutcomeNot recovered/not resolved

3)

reactionmeddraversionpt17.0ReactionTinnitusOutcomeNot recovered/not resolved

4)

reactionmeddraversionpt17.0ReactionNasal drynessOutcomeNot recovered/not resolved

5)

reactionmeddraversionpt17.0ReactionStereotypyOutcomeNot recovered/not resolved

6)

reactionmeddraversionpt17.0ReactionDry eyeOutcomeNot recovered/not resolved

7)

reactionmeddraversionpt17.0ReactionDisturbance in attentionOutcomeNot recovered/not resolved

8)

reactionmeddraversionpt17.0ReactionDizzinessOutcomeNot recovered/not resolved

9)

reactionmeddraversionpt17.0ReactionTensionOutcomeNot recovered/not resolved

10)

reactionmeddraversionpt17.0ReactionDry mouthOutcomeNot recovered/not resolved

11)

reactionmeddraversionpt17.0ReactionSleep disorderOutcomeNot recovered/not resolved

12)

reactionmeddraversionpt17.0ReactionMalaiseOutcomeNot recovered/not resolved

Drug

1)

drugcharacterization1medicinalproductSERTRALINE HYDROCHLORIDEdrugbatchnumb(CURRENT) G304727drugauthorizationnumb077713drugstructuredosagenumb100drugstructuredosageunit003drugadministrationroute048drugindicationDEPRESSIONdrugstartdateformat102drugstartdate02/10/2013actiondrug4

openFDA Info on Medication

Application Number ANDA077206, NDA020990, NDA019839, ANDA078861, ANDA077864, ANDA077106, ANDA076934 ... Brand NameSERTRALINE HYDROCHLORIDE, SERTRALINE, ZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturers Aurobindo Pharma Limited, Greenstone LLC, Rising Pharmaceuticals, Inc., Hikma Ph ... product_ndc 65862-011, 65862-012, 65862-013, 59762-0067, 59762-4960, 59762-4900, 59762-4910, ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941, 861064, 208149, 208161, 212233, 861066spl_id 80aac5d8-bb02-46f5-a8ca-5fc9f934541c, 1ef7897d-60bb-4685-820f-21c78a097642, 96aa ... spl_set_id 39a85db1-9e59-4ab0-9e18-36757f019faa, 1a58062b-e635-431a-908d-2651c6a4a21c, af2c ... Package NDC 65862-011-30, 65862-011-50, 65862-011-60, 65862-011-90, 65862-011-01, 65862-011- ... UNIIUTI8907Y6X

2)

drugcharacterization2medicinalproductADCAL-D3drugstructuredosagenumb1500drugstructuredosageunit003actiondrug5drugrecurreadministration3

Report Duplicate

duplicatesourceSANDOZduplicatenumbPHHY2014GB029621

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

9)

10)

11)

12)

Drug

1)

openFDA Info on Medication

2)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us